SK 1405
Alternative Names: SK-1405Latest Information Update: 15 Feb 2022
At a glance
- Originator Sanwa Kagaku Kenkyusho
- Class Antipruritics; Urologics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Pruritus
- Discontinued Renal failure
Most Recent Events
- 15 Feb 2022 Discontinued - Phase-I for Pruritus (In volunteers) in United Kingdom (PO)
- 15 Feb 2022 Discontinued - Phase-I for Renal failure in Japan (PO)
- 28 Dec 2021 No recent reports of development identified for phase-I development in Renal-failure in Japan (PO)